Literature DB >> 7963734

Diagnosis of Chlamydia trachomatis urethral infection in symptomatic and asymptomatic men by testing first-void urine in a ligase chain reaction assay.

M A Chernesky1, H Lee, J Schachter, J D Burczak, W E Stamm, W M McCormack, T C Quinn.   

Abstract

A multicenter study compared ligase chain reaction (LCR) of Chlamydia trachomatis plasmid DNA with culture of urethral swab specimens from 542 men (study A); a second study (B) compared LCR of first-void urine (FVU) with urethral swab cultures from 1043 men. Discordant results were resolved with direct fluorescent antibody staining of sediments from the FVU or urethral culture specimen and with a second LCR directed against a fragment of the major outer membrane protein gene. Test performance was calculated on the basis of an expanded reference standard. The LCR plasmid assay had a sensitivity of 98.0% in study A and 93.5% in study B; specificity was 99.8%-100%. The sensitivity of culturing urethral swabs from all study sites was 68.2% (range by sites, 40.0%-84.6%). The presence or absence of urethral symptoms did not alter the results. Use of this LCR test should allow more meaningful investigation and treatment of C. trachomatis infections in men.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7963734     DOI: 10.1093/infdis/170.5.1308

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  51 in total

1.  Ability of the digene hybrid capture II test to identify Chlamydia trachomatis and Neisseria gonorrhoeae in cervical specimens.

Authors:  J Schachter; E W Hook; W M McCormack; T C Quinn; M Chernesky; S Chong; J I Girdner; P B Dixon; L DeMeo; E Williams; A Cullen; A Lorincz
Journal:  J Clin Microbiol       Date:  1999-11       Impact factor: 5.948

2.  Comparison of three commercially available amplification assays, AMP CT, LCx, and COBAS AMPLICOR, for detection of Chlamydia trachomatis in first-void urine.

Authors:  W H Goessens; J W Mouton; W I van der Meijden; S Deelen; T H van Rijsoort-Vos; N Lemmens-den Toom; H A Verbrugh; R P Verkooyen
Journal:  J Clin Microbiol       Date:  1997-10       Impact factor: 5.948

3.  Detection of Chlamydia trachomatis and Neisseria gonorrhoeae by enzyme immunoassay, culture, and three nucleic acid amplification tests.

Authors:  E Van Dyck; M Ieven; S Pattyn; L Van Damme; M Laga
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

4.  Is urine leukocyte esterase test a useful screening method to predict Chlamydia trachomatis infection in women?

Authors:  J M Chow; J Moncada; D Brooks; G Bolan; H Shaw; J Schachter
Journal:  J Clin Microbiol       Date:  1996-03       Impact factor: 5.948

5.  Evaluation of bias in diagnostic-test sensitivity and specificity estimates computed by discrepant analysis.

Authors:  T A Green; C M Black; R E Johnson
Journal:  J Clin Microbiol       Date:  1998-02       Impact factor: 5.948

6.  An internal control for routine diagnostic PCR: design, properties, and effect on clinical performance.

Authors:  M Rosenstraus; Z Wang; S Y Chang; D DeBonville; J P Spadoro
Journal:  J Clin Microbiol       Date:  1998-01       Impact factor: 5.948

Review 7.  Randomised trials of STD treatment for HIV prevention: report of an international workshop. HIV/STD Trials Workshop Group.

Authors:  R Hayes; M Wawer; R Gray; J Whitworth; H Grosskurth; D Mabey
Journal:  Genitourin Med       Date:  1997-12

8.  Evaluation of the Abbott LCx ligase chain reaction assay for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in urine and genital swab specimens from a sexually transmitted disease clinic population.

Authors:  K C Carroll; W E Aldeen; M Morrison; R Anderson; D Lee; S Mottice
Journal:  J Clin Microbiol       Date:  1998-06       Impact factor: 5.948

9.  Performance of transcription-mediated amplification and ligase chain reaction assays for detection of chlamydial infection in urogenital samples obtained by invasive and noninvasive methods.

Authors:  A Stary; E Schuh; M Kerschbaumer; B Götz; H Lee
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

10.  Periodic health examination, 1996 update: 2. Screening for chlamydial infections. Canadian Task Force on the Periodic Health Examination.

Authors:  H D Davies; E E Wang
Journal:  CMAJ       Date:  1996-06-01       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.